Rigrodsky & Long, P.A. Announces Investigation of American Medical Alert Corp.

Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of American Medical Alert Corp. (“AMAC” or the “Company”) (Nasdaq: AMAC) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired by Tunstall Healthcare Group Limited (“Tunstall”) in a transaction with an approximate value of $82.3 million.

Click here to learn more and how to join the action: http://investigations.rigrodskylong.com/americanmedicalalertcorp-amac/.

Under the proposed agreement, AMAC shareholders will receive $8.55 per share in cash for every share of AMAC common stock they hold plus one Contingent Payment Right (CPR) per share providing a contingent cash payment for the holder of such common share in the event of a sale of AMAC’s interests in the Lifecomm joint venture or prior sale of Tunstall under certain conditions.

The investigation concerns whether AMAC’s board of directors adequately shopped the Company to obtain the best price possible for AMAC’s shareholders before entering into the agreement with Tunstall. Indeed, in conjunction with the acquisition, directors and officers of AMAC, holding approximately 26% of the outstanding common shares of AMAC, have agreed to vote in favor of the transaction.

If you own the common stock of AMAC and purchased your shares before September 22, 2011, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development Director, of Rigrodsky & Long, P.A., 919 N. Market Street, Suite 980, Wilmington, Delaware, by telephone at [phone], or by e-mail to [e-mail].

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.